Dynamin 2 mutations cause sporadic centronuclear myropathy with neonatal onset

Bitoun M; Bevilacqua, JA; Prudhon, B; Maugenre, S; Taratuto, AL; Monges, S; Lubieniecki F.; Cances, C; Uro-Coste, E; Mayer, M.; Fardeau, M.; Romero, NB; Guicheney, P

Abstract

We report four heterozygous dynamin 2 (DNM2) mutations in five centronuclear myopathy patients aged 1 to 15 years. They all presented with neonatal hypotonia with weak suckling. Thereafter, their phenotype progressively improved. All patients demonstrated muscle weakness prominent in the lower limbs, and most of them also presented with facial weakness, open mouth, arched palate, ptosis, and ophthalmoparesis. Electrophysiology showed only myopathic changes, and muscle biopsies showed central nuclei and type 1 fiber hypotrophy and predominance. Our results expand the phenotypic spectrum of dynamin 2-related centronuclear myopathy from the classic mild form to the more severe neonatal phenotype. © 2007 American Neurological Association Published by Wiley-Liss, Inc.

Más información

Título según WOS: Dynamin 2 mutations cause sporadic centronuclear myropathy with neonatal onset
Título según SCOPUS: Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset
Título de la Revista: ANNALS OF NEUROLOGY
Volumen: 62
Número: 6
Editorial: Wiley
Fecha de publicación: 2007
Página de inicio: 666
Página final: 670
Idioma: English
URL: http://doi.wiley.com/10.1002/ana.21235
DOI:

10.1002/ana.21235

Notas: ISI, SCOPUS